Understanding Antimicrobial Resistance Using Genome-Scale Metabolic Modeling.

Area of Science:

• Microbiology
• Computational Biology
• Systems Biology

Background:

• Antimicrobial resistance (AMR) is a critical global health threat.
• Understanding cellular responses to antimicrobials is key to developing new strategies.
• Microbial metabolism is a largely untapped resource for novel antimicrobial targets and adjuvants.

Purpose of the Study:

• To review the application of computational modeling in studying microbial metabolism.
• To explore the relationship between microbial metabolic states and antimicrobial efficacy.
• To highlight advances in genome-scale metabolic modeling for antimicrobial research.

Main Methods:

• Review of existing literature on computational modeling and microbial metabolism.
• Analysis of genome-scale metabolic models (GEMs) for phenotype prediction.
• Examination of studies linking metabolic reprogramming to antimicrobial response.

Main Results:

• Metabolic state modifications by antimicrobials predict treatment outcomes.
• Computational modeling, particularly GEMs, simplifies the analysis of complex metabolic networks.
• GEMs facilitate basic phenotype predictions and aid in identifying potential drug targets.

Conclusions:

• Computational modeling offers a powerful approach to investigate microbial metabolism and antimicrobial interactions.
• Genome-scale metabolic modeling is advancing the study of microbial responses to antimicrobials.
• Further exploitation of metabolic pathways holds promise for overcoming antimicrobial resistance.